Endometrial cancer is the most common gynecologic cancer in women today. It is surgically staged, and while surgery is the primary treatment modality, the identification of disease extent-in particular extrauterine spread-prior to surgery is important to optimize treatment decision making. Ultrasound and MRI are useful for evaluating the extent of local disease, while CT and PET are used for detecting lymph node or distant metastases. Diffusion-weighted MRI has also been used for detecting small metastatic deposits in lymph nodes and omentum. Extrauterine soft tissue involvement can be detected by ultrasound, CT, MRI, and PET. Recently, intraoperative visualization techniques, such as sentinel lymph node mapping, are increasingly used to avoid extensive surgical staging without compromising treatment. Imaging is also used for planning adjuvant treatment and detection of postoperative residual disease in high-risk patients, monitoring and detecting recurrent disease, and in post-treatment surveillance of asymptomatic patients with high risk of relapse.
| BACKGROUND
Endometrial cancer is the most common gynecologic cancer seen in women today. 1 It is more prevalent in high-resource countries, but its incidence is rising in low-resource countries as a result of rising obesity and improved longevity. Historically, endometrial cancer is classified according to histologic subtype, but recently-as a result of the Cancer Genome Atlas (TCGA)-a molecular-based classification has been advocated owing to its superior prognostication.
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Endometrial cancer is curable, especially in the early stages.
Endometrioid histology has better prognosis than nonendometrioid histologies. Surgery is the mainstay of treatment. Adjuvant radiotherapy and systemic chemotherapy play a role in selected cases. Accurate mapping of the extent of cancer spread is important for appropriate application of local and/or regional treatment. Although endometrial cancer is surgically staged, the identification of disease extent-in particular extrauterine spread-prior to surgery is important to optimize treatment planning. This has been facilitated by noninvasive medical imaging technologies including ultrasound, X-ray, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and, increasingly, co-registered images such as PET-CT or PET-MRI. More recently, intraoperative visualization techniques, such as sentinel lymph node (SLN) mapping are being used to avoid extensive surgical staging without compromising treatment.
The aim of the present article is to describe the practical application of imaging in the routine diagnostic assessment, staging, treatment selection, adjuvant treatment planning, and post-treatment surveillance of endometrial cancer patients. ultrasound to assess the pelvic organs, followed by transvaginal ultrasound to assess endometrial thickness and any extension of abnormality in the cervix. Endometrial thickness greater than 4 mm in a postmenopausal woman is highly suspicious of an endometrial pathology, warranting further evaluation that can be done with endometrial sampling. In a meta-analysis reviewing the accuracy of endometrial sampling devices, the Pipelle endometrial sampler (Pipelle de Cornier, Paris, France) was found to be highly sensitive for the detection of endometrial carcinoma, with detection rates of 99.6% and 91% for post-and premenopausal women respectively, and 81% for atypical endometrial hyperplasia. Hysteroscopy D&C should also be considered in women with bleeding who are taking tamoxifen. 
| CLINICAL PRESENTATION AND WORK-UP
Most
| STAGING AND TREATMENT SELECTION
Once a diagnosis of endometrial cancer has been established, the treatment of choice is total hysterectomy with bilateral salpingooophorectomy and surgical staging in the majority of cases. Lymph node status assessment is required for accurate staging and for treatment planning.
The detection of lymph node metastases in surgically staged patients varies between 8% and 33% depending on the quality of node dissection, pathologic assessment protocols, histologic subtype, and the clinical stage. [5] [6] [7] [8] Increasing lymph node involvement is associated with depth of myometrial invasion and histologic grade of tumor. The incidence of nodal metastases in patients with less than and greater than 50% myometrial invasion was 5%
and 18%, respectively. 5, 9 Knowledge of lymph node status assists in deciding adjuvant treatment and in radiotherapy planning. A systematic pelvic and para-aortic lymphadenectomy is associated with increased morbidity, more so in combination with radiotherapy when the incidence of serious complications can be up to 26%. 10, 11 Thus, routine systematic pelvic and para-aortic lymphadenectomy for staging purposes is not recommended. 
| Low-resource regions where medical imaging is not available
In low-resource conditions, it is reasonable to proceed with total hys- 
| Medium-resource regions where ultrasound and CT may be available
Ultrasonography plays a central role in the management of patients with gynecological disorders. It is widely available and is a relatively inexpensive imaging tool. In certain circumstances, its diagnostic accuracy may match that of MRI.
| Ultrasound
The uterine cavity and endometrium as well as the adnexa can be examined in great detail using transvaginal ultrasound. Transrectal ultrasound can also provide similar information and is useful in elderly patients with vaginal stenosis. Transabdominal ultrasound should be used in conjunction with transvaginal ultrasound if the uterus is large, and to avoid missing large ovarian or tubal pathology.
Ultrasound examination of the uterus should be carried out systematically in a stepwise fashion. 19 Using a transvaginal ultrasound probe, the cervix should be examined in a sagittal plane for tumor invasion into the cervical stroma. The medial parametria should also be examined, followed by the entire body of the uterus from cornu to cornu in a sagittal plane, and from the cervix to the fundus in an axial plan. Tumor size should then be measured and, if possible, Gordon's ratio measured at the area of deepest myometrial invasion.
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Normal endometrium in a postmenopausal woman is smooth, usually less than 1 mm thick, and has a thin hypoechoic layer between it and the myometrium (Fig. 1A,B) . Although ultrasound can detect altered endometrium, it is not specific and histologic confirmation is always required. There is a higher likelihood of endometrial cancer with increasing thickness of the endometrium and postmenopausal status.
In general, a cut-off value of 4-5 mm is indicative of a carcinoma, with 96% sensitivity and 61% accuracy based on a meta-analysis by SmithBindman et al. 20 Furthermore, the heterogeneous echogenicity caused by areas of hemorrhage and necrosis (Fig. 1C,D) and an irregular endometrial myometrial interphase that denotes myometrial invasion by cancer supports the diagnosis of endometrial cancer. Transvaginal ultrasound may also detect cervical stromal invasion.
Transabdominal ultrasound can provide additional information, mostly related to extrauterine disease.
| Computed tomography
CT is less helpful in investigating abnormalities within the uterus. Fig. 2A,B) and MRI (Fig. 2C,D) . On CT, a gross suspicious endometrial mass may be seen as a hypodense lesion, or an enlarged endometrial cavity that often cannot be distinguished from benign lesions. However, CT has better multiplanar spatial resolution that is useful in visualizing the entire pelvic and abdominal cavity for enlarged nodes (Fig. 2F ) and gross soft tissue masses, as well as distant metastases in the lungs (Fig. 2E ).
In in maximum short axis diameter. 21 It was observed that patients with single metastatic nodes tend to have tumor deposits in nodes less than 10 mm. In patients with multiple positive nodes, 85% of patients had at least one positive node greater than 10 mm. 8 In node-positive endometrial cancer patients the incidence of a single positive node was 25%-40% and multiple nodes were found in 60%-75% of patients. 8 Therefore, CT should correctly detect more than 40% of node-positive patients-higher than sensitivity and specificity studies would suggest. Additionally, CT scan of the chest, abdomen, and pelvis as a preoperative investigation is useful for excluding unexpected anatomy that may result in modification of planned surgery.
| High-resource countries where modern imaging is available
In countries where health care is streamlined and well-resourced, patients often present to the primary healthcare provider with symptoms prior to referral to a specialist or subspecialist. 
| Magnetic resonance imaging
Where available, MRI is the imaging modality of choice for the ana- Depth of myometrial invasion is related to the incidence of nodal metastasis. The incidence of nodal metastasis in patients with less than 50% and greater than 50% myometrial invasion was reported to be 5% and 18%, respectively. 5 A study comparing presurgical MRI images with histology showed the value of MRI in predicting the presence and depth of myometrial invasion (Fig. 4) and the potential utility F I G U R E 3 Normal zonal anatomy on T2-weighted MRI in (A) sagittal, (B) axial, and (C) coronal planes demonstrating high signal (bright) endometrium (arrowheads), low signal (darker) junctional zone or inner myometrium (solid white arrows), and intermediate signal (grey) outer myometrium (dotted arrows).
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F I G U R E 2 Computed tomography (A: sagittal plane, B: axial plane) and MRI (C: sagittal T2, D: axial diffusion-weighted) in the same patient with endometrial carcinoma distending the endometrial cavity (dotted arrows) and deep myometrial invasion (solid arrows). E: Axial CT chest with multiple "cannonball" pulmonary metastases (dashed arrows). F: Coronal CT abdomen demonstrating multiple para-aortic necrotic lymph node metastases (arrowheads). A minimum of at least two T2-weighted sequences in the sagittal, axial oblique, or coronal oblique orientation (short and long axis of the uterine body) of the pelvis and one T1-weighted enhanced sequence acquired at 2 minutes ±30 seconds after intravenous contrast injection is recommended.
If cervical invasion is suspected, additional slice orientation perpendicular to the axis of the endocervical canal is recommended.
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The presence of an intact enhancing cervical mucosa excludes cervical stromal invasion.
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Multiparametric MRI including thin-section (3 mm) high-resolution multiplanar T2-weighted images and simple modifications, such as the addition of double oblique T2-weighted, diffusion-weighted, and dynamic (30, 60, 120 seconds, and 4 minutes) contrast-enhanced images, improves staging and treatment planning in patients with endometrial carcinoma.
Often these preoperative images are helpful not only in planning the primary surgery, but also during deliberation of postoperative adjuvant radiotherapy for the presence of diverticula or any other variation in normal anatomy.
Metastatic node detection with MRI is similar to a high-quality CT scan with variable sensitivity ranging from 38% to 89% and specificity ranging from 78% to 99%. 26 However, DWI-MRI increasingly routine in many centers, and higher field strength 3T MRI may significantly enhance the sensitivity of detecting metastatic lymph nodes ( Fig. 5 ) by combining the size of node and relative apparent diffusion coefficient values. 27 Incorporating morphologic features of nodal involvement-best seen at high-resolution T2-weighted MRIinclude internal heterogeneity, spiculated nodal margins, necrosis, and signal intensity comparable to that in the primary tumor, improves the accuracy of evaluation in patients with rectal cancer and may be applicable to those with endometrial carcinoma. 26 DWI-MRI is also sensitive in detecting early invasive extrauterine and omental disease (Fig. 6 ). 
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MRI is useful for observing extrauterine disease and any other structural anatomical detail that may influence the extent of primary surgery.
| Positron emission tomographycomputed tomography
PET-CT is usually employed in the study of metastatic lymph nodes. It has high specificity in detecting metastatic nodes; however, its sensitivity is only modest and depends on the size of metastatic deposit.
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The detection rate of PET-CT was only 12% in metastatic lesions measuring 4 mm or less, but 100% when the deposit was 10 mm or larger. 29 It is not routinely employed in assessing intrauterine disease although it can detect depth of myometrial invasion and extension into the endocervix reasonably well. In advanced stages, PET-CT was helpful in detecting metastatic deposits in the ovary and omentum, and distant spread. In general, if the baseline MRI or CT scan suggests enlarged nodes and if one believes that removal of all positive nodes during primary surgery will offer a survival advantage, then PET-CT may be helpful in detecting the most caudal metastatic lymph node, therefore guiding the extent of nodal clearance in that patient.
Conversely, if PET-CT shows extensive disease where surgery is unlikely to be curative, then a simple (palliative) hysterectomy may be appropriate as the best immediate symptomatic measure, while the remainder of the disease can be managed using palliative hormone therapy, chemotherapy and radiotherapy alone or in combination.
| SENTINEL LYMPH NODE MAPPING
Once the diagnosis of endometrial cancer is established and no contraindication is found on preliminary clinical examination and imaging, primary surgery is planned. Surgery for endometrial cancer can range from a minimum of peritoneal assessment and washings, hysterectomy (abdominal, laparoscopic, or robotic) with bilateral salpingooophorectomy, to systematic lymphadenectomy, omentectomy, and removal of any extrauterine disease, if present.
SLN mapping involves injection of a colored dye or radioisotope tracer at both the 9 and 3 o'clock positions or at four sites in all four quadrants of the cervix (Fig. 7) . Methylene blue was used previously, CT prior to surgery may greatly assist in deciding the extent of surgery over a standard staging laparotomy. Occasionally, in poorly differentiated and high-grade histology that may have had a close resection margin, postoperative soft tissue recurrences are seen in the interval between surgery and radiotherapy. Some of these patients may require an extra radiotherapy boost requiring interstitial brachytherapy. In such cases a pre-radiotherapy pelvic MRI is very useful for identifying the tumor requiring additional radiotherapy and its relation with surrounding normal tissues.
| IMAGING IN PLANNING ADJUVANT RADIOTHERAPY

| IMAGING IN SURVEILLANCE AND FOLLOW-UP
The routine use of imaging in surveillance following initial treatment is not indicated. However, radiological imaging should be considered where a potentially salvageable recurrent disease is suspected clinically or in the post-therapeutic restaging of selected patients at high risk for relapse.
MRI can assist in identifying the extent of local recurrence and appropriateness for surgical resection and radiotherapy.
PET-CT has the additional benefit of determining if the extent of recurrence is localized or disseminated. A long interval between the primary treatment and isolated recurrence is usually associated with a better prognosis.
In a retrospective analysis of 36 women previously treated for endometrial cancer, Belhocine et al. 34 found the sensitivity and specificity of PET-CT to be 96% and 78%, respectively. These authors reported that the use of fluorodeoxyglucose (FDG)-PET confirmed recurrence in 88% of the cases, which was useful in localizing the site of disease, and it detected asymptomatic recurrence in 12%. In 35% of patients with confirmed recurrence, additional metastatic sites were detected, significantly altering management. PET has more specificity, sensitivity, and accuracy compared with conventional imaging or tumor markers.
| IMAGING AND TREATMENT OF RECURRENT ENDOMETRIAL CANCER
Patients with lymphovascular space invasion and lymph node metastases are at high risk of recurrence. 35 Eighty-seven percent of recurrences are seen by 3 years from the time of primary surgery.
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Twenty-five percent of all recurrences were solitary vaginal vault recurrences and approximately 60% had distant failure with or without locoregional recurrence.
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Solitary vaginal vault relapses can be successfully salvaged by surgery or combination of EBRT and intracavitary or interstitial brachytherapy. 38, 39 The rate of successful salvage is substantially improved and treatment complication minimized by proper patient selection using PET/CT to exclude asymptomatic multiple metastases.
MRI is particularly helpful in visualizing the treatment volume and its relationship to surrounding normal anatomical structures (Fig. 8) . 
